Parietal epithelial cell dysfunction in crescentic glomerulonephritis.
Wong MN, Tharaux PL, Grahammer F, Puelles VG.
Cell Tissue Res. 2021 Aug;385(2):345-354. doi: 10.1007/s00441-021-03513-9. Epub 2021 Aug 28.
Crescentic glomerulonephritis associated with syphilis: a case report and review of the literature.
Kaiga A, Sato Y, Arakawa H, Rai T, Tojo A.
J Med Case Rep. 2023 Dec 22;17(1):549. doi: 10.1186/s13256-023-04293-2.
Update on crescentic glomerulonephritis.
Hénique C, Papista C, Guyonnet L, Lenoir O, Tharaux PL.
Semin Immunopathol. 2014 Jul;36(4):479-90. doi: 10.1007/s00281-014-0435-7. Epub 2014 Jun 20.
[Crescentic glomerulonephritis].
Ueno M, Arakawa M.
Nihon Rinsho. 1994 Aug;52(8):2082-8.
Pauci-immune crescentic glomerulonephritis.
Gupta RK.
Indian J Pathol Microbiol. 2003 Jul;46(3):357-66.
Novel therapeutic perspectives for crescentic glomerulonephritis through targeting parietal epithelial cell activation and proliferation.
Huang Y, Zhao X, Zhang Q, Yang X, Hou G, Peng C, Jia M, Zhou L, Yamamoto T, Zheng J.
Expert Opin Ther Targets. 2023 Jan;27(1):55-69. doi: 10.1080/14728222.2023.2177534. Epub 2023 Feb 16.
Crescentic glomerulonephritis--a manifestation of a nephritogenic Th1 response?
Kitching AR, Holdsworth SR, Tipping PG.
Histol Histopathol. 2000 Jul;15(3):993-1003. doi: 10.14670/HH-15.993.
STING1 deficiency ameliorates immune-mediated crescentic glomerulonephritis in mice.
García-Giménez J, Córdoba-David G, Rayego-Mateos S, Cannata-Ortiz P, Carrasco S, Ruiz-Ortega M, Fernandez-Fernandez B, Ortiz A, Ramos AM.
J Pathol. 2023 Nov;261(3):309-322. doi: 10.1002/path.6177. Epub 2023 Aug 31.
Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis.
Syed R, Rehman A, Valecha G, El-Sayegh S.
Biomed Res Int. 2015;2015:402826. doi: 10.1155/2015/402826. Epub 2015 Nov 25.
Modulators of crescentic glomerulonephritis.
Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY.
J Am Soc Nephrol. 1996 Nov;7(11):2271-8. doi: 10.1681/ASN.V7112271.
